In vitro circulation model driven by tissue-engineered dome-shaped cardiac tissue

被引:3
|
作者
Kikuchi, Tetsutaro [1 ]
Matsuura, Katsuhisa [1 ]
Shimizu, Tatsuya [1 ]
机构
[1] Tokyo Womens Med Univ TWIns, Inst Adv Biomed Engn & Sci, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan
关键词
cell sheet technology; induced pluripotent stem cell; cardiomyocyte; tissue engineering; organ on a chip; drug screening; CELL-DERIVED CARDIOMYOCYTES; RISK-ASSESSMENT; CONSTRUCTION; FABRICATION; MATURATION; PLATFORM; COLLAGEN;
D O I
10.1088/1758-5090/ac77c1
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The heart is an essential organ for animals and humans. With the increased availability of pluripotent stem cells, the use of three-dimensional cardiac tissues consisting of cultured cardiomyocytes in in vitro drug evaluation has been widely studied. Several models have been proposed for the realization of the pump function, which is the original function of the heart. However, there are no models that simulate the human circulatory system using cultured cardiac tissue. This study shows that a dome-shaped cardiac tissue fabricated using the cell sheet stacking technique can achieve a heart-like pump function and circulate culture medium, there by mimicking the human circulatory system. Firstly, human induced pluripotent stem cells were differentiated into autonomously beating cardiomyocytes, and cardiomyocyte cell sheets were created using temperature-responsive culture dishes. A cardiomyocyte sheet and a human dermal fibroblast sheet were stacked using a cell sheet manipulator. This two-layered cell sheet was then inflated to create a dome-shaped cardiac tissue with a base diameter of 8 mm. The volume of the dome-shaped cardiac tissue changed according to the autonomous beating. The stroke volume increased with the culture period and reached 21 +/- 8.9 mu l (n = 6) on day 21. It also responded to beta-stimulant and extracellular calcium concentrations. Internal pressure fluctuations were also recorded under isovolumetric conditions by dedicated culture devices. The peak heights of pulsatile pressure were 0.33 +/- 0.048 mmHg (n = 3) under a basal pressure of 0.5 mmHg on day 19. When the tissue was connected to a flow path that had check valves applied, it drove a directional flow with an average flow rate of approximately 1 mu l s(-1). Furthermore, pressure-volume (P-V) diagrams were created from the simultaneous measurement of changes in pressure and volume under three conditions of fluidic resistance. In conclusion, this cardiac model can potentially be used for biological pumps that drive multi-organ chips and for more accurate in vitro drug evaluation using P-V diagrams.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] A tissue-engineered scale model of the heart ventricle
    MacQueen, Luke A.
    Sheehy, Sean P.
    Chantre, Christophe O.
    Zimmerman, John F.
    Pasqualini, Francesco S.
    Liu, Xujie
    Goss, Josue A.
    Campbell, Patrick H.
    Gonzalez, Grant M.
    Park, Sung-Jin
    Capulli, Andrew K.
    Ferrier, John P.
    Kosarl, T. Fettah
    Mahadevan, L.
    Pu, William T.
    Parker, Kevin Kit
    NATURE BIOMEDICAL ENGINEERING, 2018, 2 (12): : 930 - 941
  • [32] Maturation and integration of tissue-engineered cartilages within an in vitro defect repair model
    Hunter, CJ
    Levenston, ME
    TISSUE ENGINEERING, 2004, 10 (5-6): : 736 - 746
  • [33] AN IN VITRO IMMUNOCOMPETENT HUMAN TISSUE-ENGINEERED MODEL OF ATOPIC DERMATITIS FOR DRUG TESTING
    Vazquez, Inmaculada Barragan
    Danby, Simon
    Garcia Gonzalez, Vicente Marco
    Lopez Almagro, Rosa
    Crespo Crespo, Maria Isabel
    Colley, Helen
    Murdoch, Craig
    TISSUE ENGINEERING PART A, 2023, 29 (11-12) : 492 - 492
  • [34] Expression of C4.4A in an In Vitro Human Tissue-Engineered Skin Model
    Jacobsen, Benedikte
    Larouche, Danielle
    Rochette-Drouin, Olivier
    Ploug, Michael
    Germain, Lucie
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [35] Injectable Tissue-Engineered Soft Tissue for Tissue Augmentation
    Rhee, Sung-Mi
    You, Hi-Jin
    Han, Seung-Kyu
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2014, 29 : S170 - S175
  • [36] In vitro glycation of a tissue-engineered wound healing model to mimic diabetic ulcers
    Lemarchand, Mathias
    Thouin, Kiefer
    De Serres-Berard, Thiery
    Bellenfant, Sabrina
    Cadau, Sebastien
    Berthod, Francois
    BIOTECHNOLOGY AND BIOENGINEERING, 2023, 120 (06) : 1657 - 1666
  • [37] Tissue-engineered airway and "in situ tissue engineering"
    Nakamura T.
    Ohmori K.
    Kanemaru S.-I.
    General Thoracic and Cardiovascular Surgery, 2011, 59 (2) : 91 - 97
  • [38] Tissue-engineered vascular grafts TISSUE ENGINEERING
    不详
    MATERIALS TODAY, 2004, 7 (11) : 29 - 29
  • [39] In vitro evaluation of the angiostatic potential of drugs using an endothelialized tissue-engineered connective tissue
    Tremblay, PL
    Berthod, F
    Germain, L
    Auger, FA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (02): : 510 - 516
  • [40] Construction of tissue-engineered homograft bioprosthetic heart valves in vitro
    Bin, Feng
    Yinglong, Liu
    Nin, Xie
    Kai, Feng
    Son, Laifeng
    Zhu, Xiaodong
    ASAIO JOURNAL, 2006, 52 (03) : 303 - 309